摘要
妥泰作为一种新型广谱抗癫痫药物,临床上不仅用于治疗各种类型癫痫,同时还具有神经保护作用和用以治疗神经痛、减肥、特发性震颤、双相情感障碍、戒酒、面肌痉挛以及偏头痛等。
出处
《国际神经病学神经外科学杂志》
2006年第2期153-156,共4页
Journal of International Neurology and Neurosurgery
参考文献19
-
1Chriatensen J, Andreasen F, Poulsen JH, et al, Randomized,concentration-controlled trial of topiramate in refractory focal epilepsy. Neurology, 2003, 61 (9) : 1210-1218.
-
2Aykutlu E, Baykan B, Gurses C, et al. Add-on therapy with topiramate in progressive myoelonie epilepsy. Epilepsy Behav,2005, 6(2) : 260-263.
-
3Arroyo S, Dodson WE, Privitera MD, et al. Randomized dosecontrolled study of topiramate as first-line therapy in epilepsy.Aeta Neural Scand, 2005, 112(4) : 214-222.
-
4Christensen J, Andreasen F, Poulsen JH, et al. Randomized,concentration-controlled trial of topiramate in refractory focal epilepsy. Neurology, 2003, 61(9) : 1210-1218.
-
5Bootsma HP, Coolen F, Aldenkamp AP, et al. Topiramate inclinical practice: long-term experience in patients with refractory epilepsy referred to a tertiary epilepsy center. Epilepsy Behav,2004, 5(3): 380-387.
-
6Groselj J, Guerrini R, Van Oene J, et al. Experience with topiramate monotherapy in elderly patients with recent-onset epilepsy. Acta Neurol Seand, 2005, 112(3) : 144-150.
-
7Donofrio PD, Raskin P, Rosenthal NR, et al. Safety and effectiveness of topiramate for the management of painful diabetic peripheral neuropathy in an open-label extension study, Clin Ther, 2005, 27(9) : 1420-1431.
-
8Raskin P, Donofrio PD, Rossenthal NR, et al, Topiramate vs placebo in painful diabetic neuropathy: An',dgesic and metabolic effects. Neurology. 2004, 63(5) : 865-873.
-
9Ben- Menachem E, Axelsen M, Johanson EH, et al. Predictors of weight loss in adults with toplramte-treated epilepsy. Obes Res, 2003, 11 : 556-562.
-
10Nickel C, Tritt K, Muehlbacher M, et al. Topiramate treatment in bulimia nervosa patients: a randomized, double-blind,placebo-controlled trial. Int J Eat Disord, 2005, 38 ( 4 ) :295-300.
二级参考文献4
-
1胡兴越,吕文,王谨,程源深.A型肉毒毒素治疗肌张力过强[J].中国新药与临床杂志,1999,18(1):38-40. 被引量:16
-
2赵忠新,黄坚.抗癫痫新药托吡酯临床应用研究进展[J].中国新药与临床杂志,2001,20(1):65-67. 被引量:33
-
3亓法英,周红杰,赵孔波.A型肉毒毒素治疗面肌痉挛158例临床观察[J].中国神经精神疾病杂志,2001,27(5):388-389. 被引量:2
-
4常建军,梅海云,刘宪平,周秀丽,李浩,王蕾.小剂量A型肉毒毒素治疗面肌痉挛[J].中国新药与临床杂志,2002,21(6):377-377. 被引量:56
同被引文献33
-
1黄静,任榕娜,陈新民,叶礼燕.抗癫癎药妥泰对幼鼠肝毒性的实验研究[J].中国当代儿科杂志,2007,9(1):54-58. 被引量:3
-
2林华,吴立文,黄远桂,陈云春,温晓妮.海马苔藓纤维出芽及突触重组与颞叶癫痫的相关性研究[J].中华医学杂志,2007,87(5):341-344. 被引量:5
-
3Rosenfeld WE, Liao S, Kramer LD, et al. Comparison of the steady-state pharmacokinetics of topiramate and valproate in patients with epilepsy during monntherapy and concomitant therapy. Epilepsia, 1997, 38(3) : 324 -333.
-
4Latour P, Biraber A, Polard E, et al. Drug induced enceph- alopathy in six epileptic patients: topiramate? vatproate? or both? Hum Psychopharmacol, 2004, 19(3) : 193-203.
-
5Mimrod D, Specchio LM, Britzi M, et al. A comparative study of the effect of carbamazepine and valproiee acid on the pharmacokinetics and metabolic profile of topiramate at steady state in patients with epilepsy. Epilepsia, 2005 , 46 ( 7 ) : 1046-1054.
-
6Steinborn B. Pharmaeokinetic interactions of carbamazepine with some antiepileptic drugs during epilepsy treatment in chldren and adolescents. Rocz Akad Med Bialvmst, 2005, (suppl 1):9-15.
-
7Gisclon LG, Curtin CR, Kramer LD. The steady-state (ss) pharmacokinetics ( PK ) of phenytoin ( Dilantin ) and topiramate in epileptic patients on monotherapy, and during combination therapy. Epilepsia, 1994, 35 ( Suppl 8 ) : 54-55.
-
8Luszczki JJ, Czuczwar SJ. Gapaentin syrergistically interacts with topiramate in the mouse maximal electroshock seizure model: an isobolographic analysis. Pharmacological Rep, 2006, 58(16) : 944-954.
-
9Luszczki JJ. lsobolographic analysis of interaction between drugs with nonparallel does-respose relationship curves: a practical application. Naunyn Schmiedebergs Arch Pbarmacol, 2007, 375(2) : 105-114.
-
10Doose DR, Brodie MJ, Wilson EA, et al. Topiramate and lamotrigine pharmaeokinetics during repetitive monotherapy and combination in epilepsy patients. Epilepsia, 2003 , 44 ( 7 ) : 917-922.
引证文献3
-
1程基焱,高然,黄吉春,刘广益,殷菱,郑福蓉.马桑内酯致痫大鼠突触结构的变化及妥泰的保护作用[J].现代预防医学,2008,35(9):1770-1772. 被引量:2
-
2程基焱,黄吉春,高然,殷菱,刘广益,郑福蓉.癫痫大鼠血脑屏障超微结构改变及妥泰的保护作用[J].解剖学报,2008,39(4):498-501. 被引量:1
-
3何继红,孙红斌.妥泰的药物相互作用研究进展[J].国际神经病学神经外科学杂志,2008,35(5):445-448. 被引量:7
二级引证文献10
-
1张海宇,马全瑞,张焱,张莲香,王登科,孙征,王效军,秦毅.黄芪注射液对大鼠脑出血后神经的保护作用[J].解剖学报,2010,41(3):353-357. 被引量:9
-
2肖经纬,孟会林,段化伟,张志荣,王健,鱼涛,郑敏,李斌,郑玉新.丙烯酰胺对大鼠神经元突触可塑性的影响[J].中华预防医学杂志,2011,45(11):1022-1025. 被引量:6
-
3李娟,李祥丽,黄美颖,谢新星.托吡酯片单药对小儿癫痫的疗效以及预后分析[J].重庆医学,2011,40(36):3720-3721. 被引量:28
-
4韩艺,张凯,刘广益.耐药性癫痫大鼠海马MRP1与GFAP的表达及托吡酯影响的研究[J].泸州医学院学报,2012,35(4):371-375. 被引量:2
-
5龙敏跃,李彩环,梁翠苗.托吡酯片对小儿癫痫的疗效以及预后分析[J].现代诊断与治疗,2012,23(10):1708-1709. 被引量:8
-
6孙启东.托吡酯片单药对小儿癫痫的疗效及预后的影响[J].中国医药指南,2013,11(19):221-222. 被引量:2
-
7林楚鹏.妥泰治疗小儿癫痫36例分析[J].中国医药指南,2014,12(4):119-120.
-
8尚凤伟.小儿癫痫应用托吡酯片单药治疗的疗效和预后分析[J].临床医学,2016,36(6):113-114. 被引量:1
-
9刘建.复方氨基丁酸维E胶囊联合托吡酯片治疗小儿癫痫的临床研究[J].现代药物与临床,2016,31(12):1963-1966. 被引量:12
-
10袁磊,刘丹琦,李逃明,王萍,尹桃,周伯庭.丙戊酸钠与卡马西平血药浓度监测2608例次结果分析[J].中国药师,2017,20(6):1074-1078. 被引量:9
-
1林兴建,张颖冬.新型抗癫癎药物对脑缺血损伤的神经保护作用[J].临床神经病学杂志,2009,22(3):233-234. 被引量:1
-
2刘扬,高旭光.抗癫药物的非抗作用适应证[J].医药导报,2005,24(2):94-96.
-
3翟民,于长安,王孟,朱建益,郑亮.盐酸阿罗洛尔临床应用研究概述[J].药学研究,2014,33(6):357-358. 被引量:8
-
4胡兆梅.硝苯地平的临床反应[J].神经药理学报,1997(4):123-124.
-
5金瑞峰,孙若鹏,王莹.托吡酯在非抗癫痫方面的临床应用新进展[J].中国新药与临床杂志,2005,24(10):818-823. 被引量:4
-
6穆维静,任晓蕾,张海英,冯婉玉.氟西汀致疑似5-羟色胺综合征[J].药物不良反应杂志,2013,15(4):223-224.
-
7曹贵方.多中心双盲对照试验发现托吡酯能有效治疗中重度特发性震颤[J].中华医学杂志,2006,86(18):1235-1235. 被引量:1
-
8宋绍国,宋荣胜.普萘洛尔在神经科的临床应用[J].医药导报,1995,14(5):237-238.
-
9丁国林.002 老年人常用抗高血压药物的适应证与禁忌证以及合理联用与不合理联用[J].国外医学(老年医学分册),2004,25(1):41-41. 被引量:5
-
10陈春富,郎森阳.托吡酯神经保护作用研究进展[J].国际神经病学神经外科学杂志,2006,33(2):149-152. 被引量:1